Placeholder

Anti-NDRG1 Antibody Clone NDRG1/1383

$ 118.00$ 418.00
Please Select Product Options Below To View The Catalog Number.

SKU: 10397-MSM1
Species: Human
Tested Applications: Western Blot
Available Conjugates: Unconjugated
Isotype: Mouse IgG3
Mass Spec Validated?: Not MS Validated

Size
Tag Clear selection
Shipping Information
In Stock: 1-2 Day Lead Time.
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
SKU: 10397-MSM1-P0
NDRG1 General Information
Alternate Names
NDRG1
Molecular Weight
43kDa
Chromosomal Location
8q24.3
Curated Database and Bioinformatic Data
Gene SymbolNDRG1
Entrez Gene ID10397
Ensemble Gene IDENSG00000104419
RefSeq Protein Accession(s)NP_001128714, NP_001245361, NP_006087, XP_011515094, NP_001245362, XP_011515093
RefSeq mRNA Accession(s)NM_001258432, NM_001258433, NM_006096, XM_011516791, NM_001135242, XM_011516792
RefSeq Genomic Accession(s)NC_000008, NC_018919, NG_007943
UniProt ID(s)B3KWB2, Q8N959, Q92597
UniGene ID(s)B3KWB2, Q8N959, Q92597
HGNC ID(s)7679
Cosmic ID(s)NDRG1
KEGG Gene ID(s)hsa:10397
PharmGKB ID(s)PA31482
General Description of NDRG1.
This MAb recognizes a protein of 43kDa, which is identified as N-myc downstream-regulated gene 1 protein (NDRG1). The NDRG) family is comprised of four members, NDRG1, NDRG2, NDRG3 and NDRG4, which share 57-65% homology. The NDRG1 gene is ubiquitously expressed, but it is expressed most prominently in placental membranes and prostate, kidney, small intestine and ovary tissue. NDRG1 is a direct transcriptional target gene of p53 to mediated cell death and apoptosis. NDRG1 gene expression is induced by several compounds, including nickel, and produces a protein involved in stress responses, hormone responses, cell growth and differentiation. The reduced expression of NDRG1 has been found to be associated with tumor metastasis in a variety of tumors, including cancers of the breast, colon, prostate, oral cavity and oropharynx. Reportedly, overexpression of NDRG1 in hepatocellular carcinoma is an indicator of tumor aggressiveness.

Human Anti-NDRG1 Antibody Product Attributes

Species: Human
Tested Applications: Western Blot.
Clonality: Monoclonal
Anti-NDRG1 Antibody Clone: NDRG1/1383
Clone NDRG1/1383 Host and Isotype: Mouse IgG3
Anti-Human NDRG1 Positive Control Sample: HeLa Cells. Prostrate or Renal Carcinoma.
Cellular Localization of Antibody Cytoplasmic and Cell Surface
Buffer and Stabilizer: 10mM PBS with 0.05% BSA and 0.05% Azide
Antibody Concentration: 200 ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Recombinant fragment of human NDRG1 fragment (aa162-283)
Storage Conditions: Store at 2 to 8° C (refrigerate). Stable for 24 months when properly stored.

NDRG1 Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-NDRG1 antibody staining is expected to be primarily localized to the cytosol and microtubules.

Observed Antibody Staining Data By Tissue Type:

Variations in NDRG1 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in glandular cells in the adrenal gland and appendix, glial cells in the caudate nucleus and cerebral cortex, neuronal cells in the cerebral cortex, squamous epithelial cells in the cervix, uterine, glandular cells in the colon and duodenum, squamous epithelial cells in the esophagus, glandular cells in the fallopian tube and gallbladder, glial cells in the hippocampus, cells in the tubules in kidney, bile duct cells in the liver, respiratory epithelial cells in the nasopharynx, ovarian stroma cells in the ovary, islets of Langerhans in pancreas, glandular cells in the parathyroid gland, prostate, rectum and seminal vesicle, epidermal cells in the skin, glandular cells in the small intestine and stomach, cells in the seminiferous ducts in testis, squamous epithelial cells in the tonsil, urothelial cells in the urinary bladder and squamous epithelial cells in the vagina. More moderate antibody staining intensity was present in glandular cells in the adrenal gland and appendix, glial cells in the caudate nucleus and cerebral cortex, neuronal cells in the cerebral cortex, squamous epithelial cells in the cervix, uterine, glandular cells in the colon and duodenum, squamous epithelial cells in the esophagus, glandular cells in the fallopian tube and gallbladder, glial cells in the hippocampus, cells in the tubules in kidney, bile duct cells in the liver, respiratory epithelial cells in the nasopharynx, ovarian stroma cells in the ovary, islets of Langerhans in pancreas, glandular cells in the parathyroid gland, prostate, rectum and seminal vesicle, epidermal cells in the skin, glandular cells in the small intestine and stomach, cells in the seminiferous ducts in testis, squamous epithelial cells in the tonsil, urothelial cells in the urinary bladder and squamous epithelial cells in the vagina. Low, but measureable presence of NDRG1 could be seen inlymphoid tissue in appendix, glandular cells in the breast, myoepithelial cells in the breast, cells in the molecular layer in cerebellum, endothelial cells in the cerebral cortex, glandular cells in the cervix, uterine, cells in the endometrial stroma in endometrium, hepatocytes in liver, non-germinal center cells in the lymph node, exocrine glandular cells in the pancreas, smooth muscle cells in the smooth muscle, fibroblasts in mesenchymal tissue, cells in the red pulp in spleen, Leydig cells in the testis and non-germinal center cells in the tonsil. We were unable to detect NDRG1 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of NDRG1 expression as measured by anti-NDRG1 antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity ++ +++ +++ +++ +++ ++ +++ ++ +++ ++ +++ +++ +++ +++ +++ +++ +++ + + +++
NDRG1 Variability ++ ++ ++ ++ + ++ ++ +++ ++ ++ ++ ++ ++ + + ++ ++ ++ ++ +

Limitations and Warranty

enQuire Bio's NDRG1 Anti-Human Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.

There are no reviews yet.

Be the first to review “Anti-NDRG1 Antibody Clone NDRG1/1383”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif

enQuire Bio, LLC   1825 Lawrence St, Ste 115   Denver, CO 80202
Phone: 1-855-344-1400 | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email
Scroll to top

We consume cookies ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Dismiss

Anti-NDRG1 Antibody Clone NDRG1/1383